Skip to main content
. 2016 Apr 25;3(3):031407. doi: 10.1117/1.NPh.3.3.031407

Fig. 2.

Fig. 2

The burden of cerebral hypoxia in 166 extremely preterm infants included in the SafeBoosC-II randomized clinical trial. The burden was reduced to less than half in the experimental group. The control group had blinded recording of cerebral oxygenation while the experimental group had the actual cerebral oxygen displayed and could act on cerebral hypoxia with the help of a clinical guideline.